Healionics
Healionics develops vascular grafts and biomaterial scaffolds for safer and more reliable bloodstream access in dialysis patients with kidney failure. Its STARgraft vascular graft is designed to resist occlusion and infection, aiming to improve patient health and reduce the cost of dialysis care. The company’s STAR biomaterial platform supports tissue regeneration while minimizing scarring and infection in implantable devices.
Facts
- HQ
- Seattle, WA
- Sectors
- Medical Device
- Founded
- 2007
- Type
- Corporation Seattle business license
- Employees
- 9
- Registered name
- Healionics Corp Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Executives
-
Andrew Marshall Executive, Director & Chief Technology Officer
-
Max Maginness Executive, President & Chief Operating Officer
-
Mike Connolly Executive, CEO & Chairman